Peptides: Science vs. Hype — A Practical Guide
Some peptides have genuine clinical trial data behind them — and some are riding a wave of animal studies and influencer enthusiasm that has outrun the science by years.
Some peptides have genuine clinical trial data behind them — and some are riding a wave of animal studies and influencer enthusiasm that has outrun the science by years. The honest answer is that where you land on the spectrum depends entirely on which peptide you're talking about, what condition you're hoping to address, and whether the evidence behind it comes from human trials or a petri dish. Peptide interest has exploded in the last few years, and this week two of the most prominent voices in the space — Dr. Peter Attia and Ben Greenfield — published competing takes that crystallize the debate perfectly. If you've been trying to figure out who to believe, you're in the right place. Vitals Vault's PocketMD line and lab panels can help you track the biomarkers that matter if you're already using or considering peptides, but first let's make sure you understand what you're actually evaluating.
Why this is trending
Peter Attia released a full episode this week applying his characteristically rigorous, evidence-first lens to peptides — pushing hard on the question of which compounds have Phase 2 or Phase 3 human trial data versus which are extrapolated from rodent studies. At almost the same moment, Ben Greenfield published a video framing certain peptides as 'exercise mimetics,' meaning compounds that can signal your cells to behave as if they've just worked out. Both framings are partially correct, which is exactly what makes this conversation so confusing. What's genuinely new is not the peptides themselves — many have been studied for decades — but the combination of easier compounding pharmacy access, social media amplification, and a longevity-obsessed culture that is hungry for biological shortcuts. That cultural moment is real. The science, in most cases, has not caught up to the enthusiasm.
What Peptides Actually Are
Short chains of amino acids with signaling jobs
Peptides are simply short strings of amino acids — smaller than full proteins — and your body already makes thousands of them naturally to carry chemical messages between cells and organs. When you hear about 'peptide therapy,' someone is usually talking about a synthetic version of one of these natural signals, designed to amplify or mimic something your body already does.
Not all peptides work the same way or in the same place
Some peptides act on growth hormone pathways, some target inflammation, some are being studied for cognitive function, and some are claimed to replicate the cellular effects of exercise. The mechanism varies so dramatically between compounds that lumping them all together as 'peptides' is a bit like calling antibiotics and antidepressants both 'pills' — technically true but not very useful.
Most are injected, which changes the risk profile immediately
Unlike an oral supplement, most therapeutic peptides are injected subcutaneously — just under the skin — because stomach acid breaks them down before they can reach the bloodstream intact. That delivery method means sterility, dosing precision, and sourcing quality all matter in ways they simply don't with a capsule you swallow.
Lab testing
If you're using peptides that affect IGF-1, inflammation, or metabolic markers, tracking those numbers matters. The Vitals Vault starting-from-$99 panel covers 100+ tests in one visit
including the markers most relevant to peptide use
About 1 week
Schedule online — results typically within a week
Clear next steps
Guidance included, with follow-up care available
HSA / FSA
Eligible for pre-tax health spending accounts
Why Peptides Are Everywhere Right Now
Compounding pharmacies made access much easier
A few years ago, most peptides were either research chemicals sold explicitly 'not for human use' or required a specialist physician to prescribe. The growth of compounding pharmacies — and telehealth platforms willing to prescribe them — has made them dramatically more accessible, which has driven both genuine therapeutic use and a lot of unsupervised experimentation.
The longevity conversation gave peptides a new audience
As mainstream interest in biological aging, VO2 max, and healthspan has grown — driven in large part by voices like Attia — people who would never have considered injecting anything are now seriously researching peptides as optimization tools. That audience is educated and motivated, but it's also being marketed to aggressively by companies whose claims often exceed the evidence.
The 'exercise mimetic' framing is genuinely exciting — and genuinely overstated
The idea that a compound could trigger some of the cellular adaptations of exercise without the exercise itself is scientifically interesting, and there is real preliminary research behind it. But 'preliminary research' in this context usually means cell cultures or mice, not the kind of controlled human trials that would let you confidently recommend something to another person.
What the Evidence Actually Shows
GLP-1 agonists: the gold standard example
Semaglutide and tirzepatide are peptides — and they have some of the most robust human trial data of any drug class in recent memory, including large Phase 3 trials with tens of thousands of participants. They are the proof that peptides can be genuinely transformative medicines. They are also the exception, not the rule.
Growth hormone secretagogues: promising but incomplete
Compounds like sermorelin and ipamorelin stimulate your pituitary gland to release more growth hormone rather than injecting growth hormone directly, which is considered a safer approach. There is human trial data supporting their use in growth hormone deficiency, but the evidence for using them in healthy adults for anti-aging or body composition is much thinner — mostly small studies and extrapolation.
BPC-157: fascinating in animals, unproven in humans
BPC-157 is probably the most talked-about 'healing' peptide right now, with compelling rodent data showing accelerated tendon, gut, and nerve repair. The problem is that as of now there are no published Phase 2 human trials — which means you are essentially running an experiment on yourself with no human safety or efficacy data to guide dosing or duration.
TB-500 and 'exercise mimetics': early signal, long way to go
Thymosin beta-4 (TB-500) and compounds like MOTS-c are being studied for their ability to activate cellular repair and metabolic pathways that overlap with exercise adaptation. The biology is real and interesting. But 'interesting biology in a lab' and 'proven benefit in a human being taking a specific dose' are separated by a decade of trials that mostly haven't happened yet.
Myths vs. Facts
Myth: 'Natural' peptides are automatically safe
Because many therapeutic peptides mimic compounds your body already makes, there's a common assumption that they're inherently safe. But dosing, timing, purity, and delivery method all create risks that don't exist with endogenous levels — and synthetic versions sourced from unregulated suppliers may contain contaminants that have nothing to do with the peptide itself.
Myth: Animal study results translate directly to humans
Rodents heal dramatically faster than humans, have different hormonal environments, and are often studied at doses that would be enormous relative to body weight in a person. A peptide that regenerates a rat's torn tendon in two weeks is genuinely exciting science — but it tells you almost nothing about what will happen in your shoulder over six months.
Myth: If a doctor prescribes it, the evidence must support it
Physicians can legally prescribe compounded peptides off-label, and many do so in good faith based on the best available evidence. But 'legally prescribed' is not the same as 'proven effective in humans at this dose for this purpose,' and it's worth asking your prescriber specifically what trial data they're drawing on when they recommend a particular compound.
Risks and Caveats Worth Taking Seriously
Sourcing quality is a genuine safety issue
Peptides sold as 'research chemicals' online are not manufactured to pharmaceutical standards, which means contamination, mislabeling, and incorrect concentrations are real possibilities — not theoretical ones. If you're going to use a peptide, getting it through a licensed compounding pharmacy with a valid prescription is meaningfully safer than ordering from a supplement website.
Growth hormone pathways carry long-term unknowns
Chronically elevating growth hormone or insulin-like growth factor 1 (IGF-1) — which several popular peptides do — is not a neutral act. Elevated IGF-1 has been associated with increased cancer risk in some epidemiological studies, and the long-term effects of sustained secretagogue use in healthy adults simply haven't been studied. This doesn't mean the risk is certain, but it means it's not zero.
Stacking multiple peptides multiplies the unknowns
A common pattern in the biohacking community is combining several peptides simultaneously to target multiple pathways at once. Even if each compound had solid individual safety data — which most don't — the interaction effects between them are essentially unstudied. The more compounds you add, the harder it becomes to attribute any effect, positive or negative, to a specific one.
Frequently Asked Questions
Which peptides actually have human clinical trial data?
GLP-1 agonists like semaglutide have the strongest human trial data of any peptide class. Growth hormone secretagogues like sermorelin have human data for diagnosed deficiency but limited data for healthy adults. Most other widely discussed peptides — including BPC-157 and TB-500 — have compelling animal data but no published Phase 2 human trials as of mid-2026.
Is BPC-157 safe to use?
The honest answer is that we don't know yet, because there are no completed human safety trials. The rodent data is encouraging and hasn't shown obvious toxicity, but rodent studies don't reliably predict human outcomes. If you're considering it, that conversation should happen with a physician who can weigh your specific health history against the current state of the evidence.
What's the difference between a peptide and a regular supplement?
Most supplements are small molecules, vitamins, or plant extracts that you swallow and absorb through your gut. Peptides are chains of amino acids that typically need to be injected because stomach acid breaks them down before they can reach your bloodstream intact. That difference in delivery method means the safety considerations, sourcing requirements, and regulatory oversight are all substantially different.
Can peptides really mimic the effects of exercise?
Some peptides activate cellular pathways that overlap with those triggered by exercise — this is real biology, not pure fiction. But 'activating a pathway' in a lab setting and 'producing the cardiovascular, metabolic, and structural benefits of regular physical activity in a human body' are very different things. The exercise mimetic framing is scientifically interesting but currently far ahead of the human evidence.
How do I know if a peptide is worth the risk for me personally?
Start by asking what human trial data exists for that specific peptide at the dose being recommended for your specific goal — not animal data, not anecdotes. Then consider whether your baseline biomarkers (including IGF-1 if relevant) have been measured so you have something to compare against. Vitals Vault's lab panels can establish that baseline, and a PocketMD physician can help you interpret whether the evidence actually supports the use case you have in mind.